ConductScience.org, home
A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.
API referenceFor AI assistants

Trial · NCT03580356

Participant flow72

How many started, completed or left each group, period by period.

1 to 20 of 72

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Treatment PeriodSTARTEDLigelizumab 72 mg - Adults307
Treatment PeriodSTARTEDLigelizumab 72 mg - Adolescents16
Treatment PeriodSTARTEDLigelizumab 120 mg - Adults304
Treatment PeriodSTARTEDLigelizumab 120 mg - Adolescents19
Treatment PeriodSTARTEDOmalizumab 300 mg - Adults309
Treatment PeriodSTARTEDOmalizumab 300 mg - Adolescents14
Treatment PeriodSTARTEDPlacebo - Ligelizumab 120mg - Adults103
Treatment PeriodSTARTEDPlacebo - Ligelizumab 120mg - Adolescents6
Treatment PeriodRandomized Set (RAN)Ligelizumab 72 mg - Adults307
Treatment PeriodRandomized Set (RAN)Ligelizumab 72 mg - Adolescents16
Treatment PeriodRandomized Set (RAN)Ligelizumab 120 mg - Adults304
Treatment PeriodRandomized Set (RAN)Ligelizumab 120 mg - Adolescents19
Treatment PeriodRandomized Set (RAN)Omalizumab 300 mg - Adults309
Treatment PeriodRandomized Set (RAN)Omalizumab 300 mg - Adolescents14
Treatment PeriodRandomized Set (RAN)Placebo - Ligelizumab 120mg - Adults103
Treatment PeriodRandomized Set (RAN)Placebo - Ligelizumab 120mg - Adolescents6
Treatment PeriodSafety Set (SAF)Ligelizumab 72 mg - Adults304
Treatment PeriodSafety Set (SAF)Ligelizumab 72 mg - Adolescents16
Treatment PeriodSafety Set (SAF)Ligelizumab 120 mg - Adults306
Treatment PeriodSafety Set (SAF)Ligelizumab 120 mg - Adolescents19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03580356/flow

API referenceFor AI assistants